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ABSTRACT Microarraying allows the spatial and compositional control of surfaces, typically for the purpose of binding
reactions. Collagen and/or von Willebrand Factor (vWF) in 5% glycerol was contact printed onto glass slides to create deﬁned
microspots (176-mm diameter) of adsorbed protein without sample dehydration. The arrays were mounted on ﬂow chambers
allowing video microscopy during perfusion (wall shear rate of 100–500 s1) of recalciﬁed corn trypsin inhibitor-treated whole
blood or platelet rich plasma and subsequent array scanning via anti-GPIba and anti-ﬁbrin(ogen) immunoﬂuorescence. To
mimic the subendothelial matrix, vWF was microarrayed over sonicated type I collagen microspots. For whole blood perfusion
(500 s1, 10 min) over collagen, vWF, and collagen/vWF microspots, the amount of platelet deposition on the collagen/vWF spots
was ;2 times greater in comparison to the collagen spots and ;18 times greater in comparison to the vWF spots. The amount of
ﬁbrin(ogen) deposition on the collagen/vWF spots was;2 times greater in comparison to the collagen spots and;4 times greater
in comparison to the vWF spots. This protocol allowed for highly uniform (CV ¼ 18%) and precisely located thrombus formation at
a density of$400 spots/cm2. Microarrays are ideal for the combinatorial assembly of adhesive and procoagulant proteins to study
thrombosis as well as to study axial and lateral transport effects between discrete microspots of distinct composition.
INTRODUCTION
Since blood is a moving biological ﬂuid in vivo, it is impor-
tant to study blood phenotype in vitro under ﬂow conditions
whereby the ﬂowing blood or blood cells come in contact
with a uniformly coated surface or a micropatterned surface.
Cells convect along the surface and threshold levels of ﬂow
at wall shear rate, gw; 100 s
1 (wall shear stress of tw ; 1
dyne/cm2) facilitate platelet glycoprotein (GP) Ib binding
to von Willebrand factor (vWF) (1) or neutrophil 2selectin
glycoprotein-1 (PSGL-1) binding to P- or L-selectin (2,3).
Also, shear forces on adherent cells cause bond loading with
consequent reduction of bond lifetime (1,4). In terms of cell
rheology, membrane tethering (5) and cell deformation (6)
during shear exposure can shield bonds from hemodynamic
force loading or enhance contact areas.
For adhesion and thrombosis research, prior studies have
used tubular or parallel-plate perfusion devices with well-
characterized ﬂow ﬁelds to investigate processes of blood
cell adhesion and blood coagulation at controlled wall shear
rates (gw). At venous wall shear rates (;50–250 s
1) plate-
lets can efﬁciently adhere and ﬁrmly arrest on collagen sur-
faces (7–9). At arterial wall shear rates (;500–2000 s1),
surface bound vWF greatly facilitates capture and translo-
cation via platelet glycoprotein (GP) Ib, which is constitu-
tively present (10,11) before the slower engagement of
platelet GPVI binding/clustering on collagen and consequent
activation of the collagen receptor integrin a2b1 and the
ﬁbrinogen receptor integrin aIIbb3 (GPIIb/IIIa) (12).
Thrombus formation can be initiated by either disruption
of the endothelium lining of blood vessels, exposing the sub-
endothelial matrix or by atherosclerotic plaque rupture. The
tissue factor (TF) pathway is the primary trigger for coagula-
tion initiation in vivo when wall-derived TF is exposed to the
blood. As a cofactor, TF binds active Factor VII (FVIIa) and
the TF/VIIa complex activates Factor X to Factor Xa. Factor
Xa along with Factor Va forms the prothrombinase complex
to cleave prothrombin to produce thrombin. Also, Factor XIa
activates Factor IX to IXa, which is part of the intrinsic
tenase complex, IXa/VIIIa. The role of blood-borne TF re-
mains an area of active investigation. Thrombin cleaves
ﬁbrinogen to form the ﬁbrin monomer; the monomer poly-
merizes to form a ﬁbrin mesh within and around the platelet
plug.
Several mathematical treatments of thrombosis have been
developed to describe the deposition of blood cells and the
triggering of coagulation on a surface. By imposing a throm-
bus growth rate and ﬂux of ADP, thromboxane A2, and
thrombin, Hubbell et al. performed a computational study to
simulate the concentration proﬁles of released platelet acti-
vating factors as they dilute in a ﬂow ﬁeld (13). The model
predicted an active cloud of these compounds around the
thrombus and the size of this cloud decreases with increasing
shear rate. Folie and McIntire (14) extended that simulation
to account for ﬂow recirculation and ADP/thromboxane
accumulation between two thrombi. For plasma protease
cascades, the kinetics of TF-triggered coagulation (15) and
plasminogen activator-triggered ﬁbrinolysis (16) have been
realistically modeled. More recently, Kuharsky and Fogelson
(17) developed a full transport-reaction coagulation model
that takes into account surface-dependent reactions, transport
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of chemicals and cells due to ﬂow, and populations of resting
and activated platelets. In the Kuharsky-Fogelson model, con-
vection and diffusion processes were treated with a mass
transfer coefﬁcient between the bulk blood compartment to a
well-mixed, thin, and small (103 10 mm) compartment near
the surface, thereby converting a difﬁcult multi-component
convection-diffusion problem into a transient problem where
spatial gradients are not needed or calculated and a thrombus
mass does not grow with time.
Motivated by the spatially discrete thrombotic scenarios in
the Folie-McIntire model and the Kuharsky-Fogelson model
as well as the focal nature of thrombosis in vivo, we have
developed a microarray-based technique to investigate blood
cell adhesion and blood coagulation under controlled laminar
ﬂow. This system allows for spatially and chemical deﬁned
surfaces to be exposed to blood cells under well-controlled
hydrodynamic conditions. This method also allows for a com-
binatorial exploration of matrix protein mixtures in a single
ﬂow chamber experiment. Spot-to-spot communication and
species transfer, laterally and axially, can be studied with
matrix microarrays. This approach extends the commonly used
method of coating an entire surface with a protein or mixture
of proteins. We demonstrate the technique is repeatable, ex-
tendable, and quantiﬁable.
MATERIALS AND METHODS
Materials
Native collagen ﬁbrils (type I) from equine tendons suspended in isotonic
glucose solution of pH 2.7 (Nycomed Pharma GmbH, Unterschleissheim,
Germany), human plasma von Willebrand Factor (Calbiochem/EMD Bio-
sciences, San Diego, CA), mouse monoclonal anti-human CD42b (GPIba)
(Research Diagnostics, Flanders, NJ), FITC-conjugated rabbit anti-human
ﬁbrin/ﬁbrinogen, FITC-conjugated sheep anti-human vonWillebrand Factor
(Accurate Chemical & Scientiﬁc, Westbury, NY), rabbit anti-collagen type I
(Fitzgerald Industries International, Concord, MA), Zenon Alexa Fluor 647
Mouse IgG1 Labeling Kit and Zenon Alexa Fluor 647 Rabbit IgG Labeling
Kit (Molecular Probes, Eugene, OR), corn trypsin inhibitor (Haematologic
Technologies, Essex Junction, VT) human serum albumin (Golden West
Biologicals, Temecula, CA), bovine serum albumin and sodium citrate
(Sigma-Aldrich, St. Louis, MO), and phosphate buffered saline (PBS) with-
out calcium chloride or magnesium chloride (Invitrogen, Carlsbad, CA)
were stored according to the manufacturers’ instructions. Human blood was
collected from healthy donors via venipuncture and anticoagulated with
sodium citrate (9 parts blood to 1 part sodium citrate). To prepare platelet
rich plasma (PRP), whole blood was centrifuged at 120 g and the supernatant
(PRP) was removed for the experiments. Before perfusion, the plasma was
treated with CTI (50 mg/ml) to block Factor XIIa and associated intrinsic
pathway initiation (18) and then was recalciﬁed with CaCl2 to a ﬁnal calcium
concentration of 20 mM.
Protein array printing
An OmniGrid Accent (Genomic Solutions, Ann Arbor, MI) robotic contact
microarrayer was used for arraying with a 13 1 pin protocol with an ArrayIt
Stealth Micro Spotting Pin SMP-4 (Telechem International, Sunnyvale,
CA). Before printing, plain glass slides (25 3 75 3 1.0 mm, SuperFrost
Plus, Fisher Scientiﬁc, Pittsburgh, PA) were incubated with 1 M NaOH for
15 min and rinsed extensively using distilled water. The slides were then
rinsed brieﬂy in ethanol and vacuum-dried. After preparing the slides, col-
lagen (50–1000 mg/ml) and vWF (10–100 mg/ml) in 5% v/v glycerol, either
alone or in different combinations, were printed via robotic contact printing.
Arraying occurred at 50% relative humidity to prevent evaporation. The pin
yielded spot sizes of 176 6 28 mm in diameter for the collagen solution
and 1766 57 mm in diameter for the vWF solution. After printing, the slides
were stored at 4C until use and then equilibrated to room temperature before
perfusion experiments.
Perfusion of blood components
A parallel-plate perfusion chamber was used as previously described (19).
The wall shear stress, tw (dyne/cm
2) was calculated by tw ¼ 6 Qm/B2W,
where Q is the volumetric ﬂow rate (cm3/s), m (poise) is the viscosity of the
ﬂuid, B is the separation between the plates (0.02 cm), andW (1.11 cm) is the
ﬂow chamber width. The viscosity of whole blood is 0.04 poise at 37C (20)
and 0.047 poise at 25C (21); the viscosity of plasma is 0.012 poise at
37C (20) and 0.018 poise at 25C (21). The wall shear rate, gw (sec1) was
calculated from gw ¼ 6 Q/B2W. Perfusion of 1% (w/v) human serum
albumin (HSA) in PBS at a wall shear rate of 25 s1 for 15 min was used to
rinse the glycerol from the microspots and to prevent nonspeciﬁc binding.
Recalciﬁed PRP or whole blood was then perfused at room temperature over
the slide at various shear rates by withdrawal using a syringe pump (Harvard
Apparatus, Holliston, MA). After perfusion with the blood components, the
slide was rinsed with 3% (w/v) bovine serum albumin (BSA) in PBS. Dur-
ing ﬂow experiments, the parallel-plate ﬂow chamber was mounted on a
Zeiss Axiovert 135 microscope (Carl Zeiss, Thornwood, NY) with a 203
(NA 0.30) objective lens (LD Achrostigmat) for phase contrast microscopy
and video imaging (Fig. 1).
Immunostaining and array scanning
To ensure the thrombogenic proteins were adherent to the glass, printed
slides were probed with ﬂuorescent antibodies against collagen and vWF.
Anti-collagen was ﬂuorescently labeled using Zenon Alexa Fluor 647
Rabbit IgG Labeling Kit according to the manufacturers’ instructions. The
labeled anti-collagen and FITC conjugated anti-vWF was diluted 1:100 with
3% BSA solution. The slide was incubated with the antibody solution for
1 h and rinsed with 3% BSA before imaging. After the blood perfusion
experiment, the adherent cells were ﬁxed with 2% paraformaldehyde in PBS
for 20 min and rinsed with NH4Cl to quench any unreacted aldehyde. Anti-
CD42b was ﬂuorescently labeled using Zenon Alexa Fluor 647 Mouse IgG1
Labeling Kit according to the manufacturers’ instructions. The labeled anti-
CD42b and FITC conjugated anti-ﬁbrin/ﬁbrinogen was diluted 1:50 with 3%
BSA solution. The slide was incubated with the antibodies for 1 h and rinsed
with 3% BSA. The slides were then scanned and imaged using a cooled
CCD microarray scanner (Alpha Array 8000; Alpha Innotech, San Leandro,
CA) with Cy-5 and FITC ﬁlter sets. The raw images were quantiﬁed for
ﬂuorescent intensity using ArrayVision 6.3 (Imaging Research, St. Catharines,
Ontario). The ﬂuorescent intensity was background subtracted for each spot
by using local background estimates from four regions around the spot. The
number of platelets within microspot was determined via the following
protocol: Gel-ﬁltered platelets were allowed to adhere on collagen microspots
for 30 min at room temperature. Platelets were ﬁxed, immunostained, and
imaged. Then platelets were also imaged at 403 magniﬁcation using a Zeiss
Axioplan microscope. The number of platelets was determined for 15 ﬁelds of
view with dimensions of 222.79 mm by 166.93 mm. The ﬂuorescent intensity
and area of the microspots were determined for 400 spots. The number of
platelets in the microscope ﬁeld of view was divided by the ﬂuorescent
intensity per area of the microspot. This value yielded the average ﬂuorescent
intensity per platelet which was used to calibrate the number of platelets
within each microspot.
Microspot Thrombosis under Flow 3475
Biophysical Journal 91(9) 3474–3481
RESULTS
Printing matrix proteins
Using a collagen ﬁbril suspension for contact arraying, we
observed relatively poor spot morphology. The collagen
spots had a jagged and uneven morphology and nonuniform
feature size (Fig. 2 A). To address this issue, the collagen sus-
pension was sonicated using a Sonic Dismembrator (Fisher
Scientiﬁc, Model 550) for 30 s (3 pulses, 10 s each). The soni-
cated collagen was then printed at three concentrations (50,
100, and 1000 mg/ml) with 1000 mg/ml yielding the spots
with the best morphology (Fig. 2 A). To verify the absence
of protein carryover when printing different proteins, wells of
collagen or vWF were microarrayed and then immunostained
(Fig. 2 B). The printed spots remained in their designated
location with no spot-to-spot protein carryover.
Localized thrombus formation
Utilizing video microscopy, individual microspots were
visualized during perfusion. Dilute (1:3) recalciﬁed CTI-
treated platelet-rich plasma was perfused over collagen
microspots at a wall shear rate of 500 s1 (Fig. 3). Platelet
adhesion only occurred at the area where each microspot was
initially printed. During the ﬁrst 5 min of perfusion, there
was a low level of platelet deposition which was followed by
a marked enhancement of platelet-mediated platelet capture
between 5 and 10 min. Elongated masses of platelet aggre-
gates were ;25–50 mm wide and propagated downstream
from nucleation sites found particularly at the leading edge
of the collagen microspot and to a lesser extent at the distal
edge. After 10 min, the thrombus growth reached steady
state where the rate of accumulation was approximately
equal to the rate of platelet embolization. Also, the ﬂow ﬁeld
was clearly disrupted by the growing thrombus as seen
by platelet streak lines (Fig. 3, 20 min). At 500 s1 and
20 min, abundant ﬁbrin strands were not readily visible,
consistent with previous experiments with undiluted CTI-
treated plasma perfusion over preadhered convulxin-acti-
vated platelets (22) where ﬁbrin formed at t . 35 min.
After dilute PRP perfusion for 20 min and GPIba and
ﬁbrin(ogen) immunostaining, high resolution microscope
FIGURE 2 Discrete thrombogenic protein areas. (A)
1 mg/ml type I collagen (either sonicated or not) was
printed on glass. (Scale bar¼ 200mm) (B) 1mg/ml collagen
Type I and 100 mg/ml von Willebrand Factor were printed
on glass. Slide was probed with Alexa 647 labeled anti-
collagen Type I (left panel) and FITC labeled anti-von
Willebrand Factor (middle panel). The overlay is shown in
the right panel.
FIGURE 1 Schematic of novel microarray-based perfu-
sion assay.
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imaging revealed detectable but sparse ﬁbrin strands (lack-
ing GPIba staining), individual platelets, platelet aggregates
presenting GPIba and platelet bound ﬁbrinogen (likely due
to GPIIb/IIIa activation) (Fig. 4 A). For high throughput
analysis of 100 individual collagen-microspot thrombi with-
in a 53 5 mm area, the microarray was two-color imaged at
4 mm resolution (Fig. 4 B). The individual microspot thrombi
were quite uniform in the direction of ﬂow and for the 10
replicate ‘‘lanes’’, each presenting 10 spots in the direction
of ﬂow, the staining was also quite uniform from lane to lane.
For anti-GPIba staining, the average ﬂuorescent intensity
was 1534 6 281 (CV ¼ 18%). For anti-ﬁbrinogen staining,
the average ﬂuorescent intensity was 2667 6 256 (CV ¼
10%) (Fig. 4 C). These values were determined for a single
experiment (N ¼ 100). The uniformity of the microthrombi
spot intensities in the direction of ﬂow indicated that there
was minimal consumption of platelets (i.e., no boundary
layer depletion).
Thrombosis on vWF-collagen microspots
To vary the matrix proteins on the printed surface, we wanted
to combine various thrombogenic proteins within the micro-
spot, speciﬁcally collagen and vWF. In the ﬁrst approach, we
combined vWF and collagen in the well before printing.
Contrary to expectation, the vWF/collagen spots produced
less platelet thrombosis at 500 s1 (10 min) than collagen
alone (data not shown) indicating that the collagen concen-
tration may have been reduced by coprinting with vWF. This
was in fact the case as veriﬁed by anti-collagen immunos-
taining of collagen and vWF/collagen spots (Fig. 5 A) where
premixing with vWF caused.80% reduction of the collagen
antigen maintained in the dual vWF/collagen microspot. To
overcome this limitation, we tested a method where vWF
was printed on top of collagen microspots. This second ap-
proach produced essentially the same amount of collagen as
the spots with collagen alone (Fig. 5 B). Quantiﬁcation of the
collagen spots showed that the ﬂuorescent intensity of the
collagen and vWF was 5660, whereas the ﬂuorescent inten-
sity of the collagen alone was 5812 (Fig. 5 C). This value
was not statistically different from the collagen only spots
(p ¼ 0.5014), whereas the difference between the collagen
and collagen/vWF was signiﬁcantly different for the mixing
method (p , 0.0001).
A study to demonstrate the utility of this assay involved a
comparison of thrombus formation on collagen/vWF versus
collagen alone or vWF alone. Recalciﬁed CTI-treated whole
blood was perfused over a single array with collagen, vWF,
and collagen/vWF at a wall shear rate of 500 s1 for 10 min.
The collagen/vWF spots had signiﬁcantly more thrombus
formation in comparison to that produced on collagen or
vWF alone (Fig. 6 A). The amount of platelet deposition, as
determined by ﬂuorescent intensity, on the collagen/vWF
spots was ;2 times greater in comparison to the collagen
spots and;18 times greater in comparison to the vWF spots.
FIGURE 3 Localized thrombus formation. Time lapse images of threefold
dilution of platelet-rich plasma (500 s1) treated with corn trypsin inhibitor
perfusion over a single collagen spot for 20 min. White circle represents area
of the original collagen spot. (Scale bar ¼ 25 mm).
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Using individual platelet GPIba normalization ﬂuorescence,
the average number of adherent platelets was 57 to vWF
spots, 472 to collagen spots, and 1030 to the collagen/vWF
spots. The amount of ﬁbrinogen deposition on the collagen/
vWF spots was ;2 times greater in comparison to the
collagen spots and ;4 times greater in comparison to the
vWF spots (p, 0.0001). As seen in Fig. 4, the deposition of
platelets was very uniform from spot to spot, either in the direc-
tion of ﬂow or transverse to the ﬂow.
DISCUSSION
We have developed a new approach that incorporates
microarray techniques and perfusion technologies to study
mechanisms of thrombus formation. We have shown that
this method allows for discrete thrombogenic areas for blood
to interact under ﬂow (Fig. 2). The low value for the
coefﬁcient of variation (Fig. 4 C) indicates that the cell
deposition and thrombus growth was uniform perpendicular
to the direction of ﬂow. The method can be expanded to
allow for high throughput data collection using small blood
samples.
Issues of space and time in thrombus formation have been
investigated in previous studies. Up until now, thrombus
formation was typically visualized experimentally over large
thrombogenic areas or the ﬁeld of view was in a portion of
the thrombogenic surface. This microarray method allows
for visualization at a deﬁned start and end of the thrombo-
genic area. Issues of cell deposition at the leading edge of a
thrombogenic surface can be investigated using printed
microarrays. Also, the method can become useful for issues
of critical thresholds: what area and surface concentrations
are needed to trigger or sustain clotting as a function of
prevailing shear rate.
FIGURE 4 Speciﬁc component labeling and deposition
uniformity. (A) Images taken within a single collagen spot
after a 20-min perfusion of platelet-rich plasma at 100 s1
and immunostaining. Green image represents FITC anti-
ﬁbrinogen label, red image represents Alexa 647 anti-
GPIba, and the last image is an overlay. (Scale bar ¼ 20
mm) (B) Images of a 10 3 10 collagen array after 20 min
perfusion of dilute platelet-rich plasma at 500 s1 and im-
munostaining. Left panel represents staining with Alexa
647 anti-GPIba, and the right panel represents FITC anti-
ﬁbrinogen. (Scale bar ¼ 500 mm) (C) Spot deposition
displays high degree of uniformity. Column averages of
ﬂuorescent intensity (density measurement) are plotted
against the spot center position in the direction of ﬂow for
a single experiment: dilute PRP perfusion at 500 s1 for
20 min over a 103 10 collagen array. Black bars represent
anti-ﬁbrinogen labeling and the white bars represent anti-
GPIba. Data are represented as average 6 SD (N ¼ 10).
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When printing collagen and vWF mixtures, the poor col-
lagen deposition may be due to collagen binding vWF via the
A1 domain and the A3 domain (23). The A3 domain-collagen
interaction may be particularly relevant. Two related patients
with a mutation in the A3 domain had reduced binding of
vWF to collagen (24) and also, vWF lacking A3 domain
displays very poor collagen binding (25). These interactions
may shield the collagen and prevent it from being exposed
FIGURE 5 Printing multiple proteins—mixing
versus double printing. (A) Images from two printed
protein arrays ﬂuorescently labeled for collagen. 1),
Collagen and collagen/vWF (mixed in a solution)
were printed in two 8 3 10 arrays. (B) Images from
printed protein arrays. 2), Collagen and collagen
with vWF printed atop the collagen spots were
printed in two 53 10 arrays (Scale bar ¼ 200 mm).
(C) Quantiﬁcation of ﬂuorescent intensity from the
two printing methods. Upper panel represents the
data from the premixed method; lower panel rep-
resent the double printing method. N ¼ 160 for the
premixed method and N ¼ 100 for the overprint
method. *P , 0.0001.
FIGURE 6 (A) Images of three 33 30 arrays
after a 10 min whole blood perfusion at 500 s1
(Scale bar ¼ 500 mm). (B) Higher magniﬁca-
tion images of the thrombus indicated by the
arrow in A. (Scale bar ¼ 100 mm) (C) Quanti-
ﬁcation of the ﬂuorescent intensity. Black bars
represent intensity from anti-ﬁbrinogen images;
white bars represent intensity from anti-GPIba
images. N ¼ 90.
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on the glass surface when it is mixed before printing. Since
plasma-derived vWF or vWF from alpha granules of acti-
vated platelets adheres to the exposed collagen in a layered
fashion (26), the double-print method of collagen/vWF is a
suitable representation of an in vivo thrombotic surface.
Whole blood was perfused over collagen, vWF, and
collagen/vWFmicrospots to show the difference in thrombus
formation on these combinations of extracellular matrix pro-
teins. The collagen/vWF spots had signiﬁcantly more platelet
adhesion/aggregation and ﬁbrin(ogen) deposition than either
protein on its own. These results are expected since the extra-
cellular matrix consists of both collagen and vWF, and these
proteins work in a synergistic fashion to mediate the most
efﬁcient hemostatic response at higher shear rates.
Future work using this method will focus on investigating
the effects of space and time on thrombus formation. For ex-
ample, investigating the kinetics of platelet adhesion and ag-
gregation at a well-deﬁned interface will be useful to further
understanding hemostasis and thrombosis. Several studies
have investigated areas of thrombus formation and blood
cell adhesion under static conditions (27,28). However, few
ﬁbrin studies have investigated the kinetics and timescales
of formation and platelet adhesion and embolism (29,30).
This may be due to a lack of tools to be able to study these
questions. With this system, kinetic issues can be investi-
gated in real time on a localized surface; this surface can be
chemically modiﬁed to mimic in vivo conditions. Another
example of a possible future study is evaluating the transport
mechanisms of procoagulant and platelet activating species
in a spatially deﬁned setting.
Microarrays and microprinting enable mRNA and single
nucleotide polymorphisms (SNPs) proﬁling as well as anti-
gen proﬁling via antibody arrays (31–33). Microarrays can
also be used for high throughput screening (HTS) of chem-
ical libraries against biochemical or cellular targets (34,35)
and allow for reverse transfection of plasmid or siRNA
(34,36). With respect to cardiovascular applications, endo-
thelial cells have been cultured on printed areas of extracel-
lular matrix (37). In this study, we have added the element of
convection over printed microarrays for real time study
blood coagulation.
In summary, we have presented a new method that allows
for localized thrombus formation, which can be controlled
spatially and temporally. It is a highly customizable system
that can be used to study various problems regarding
hemostasis and thrombosis. The advances of this technique
include: localized thrombotic areas which can be varied in
size, the ability to perform hundreds of experiments during a
single perfusion, and the ability to adjust the spot compo-
sition.
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